Besides, the insignificant alterations and IFN-γ-stimulated PD-L1 expression in diverse cancer cell lines after MAPK inhibitor treatment shed light on the individual regulatory role of PD-L1 in various cancer types [62, 260]. The gene discussed is IFNG; the disease is cancer.